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Summary
Background:  Plasma  ﬁbrinogen  is  considered  as  a  positive  mediator  between  mental  stress  and
cardiovascular  disease  because  it  is  an  acute-phase  protein  released  in  response  to  mental
stress and  a  coagulation  factor.  However  those  three  factors  have  never  been  studied  together
within a  single  integrated  framework,  using  cardiac  troponin  T  as  a  marker  of  cardiovascular
risk.
Methods: 491  disease-free  men  and  women  aged  53—76  were  tested  for  ﬁbrinogen  levels  before,
immediately  after,  and  following  recovery  from  standardized  mental  stress  tasks.  We  measured
plasma cardiac  troponin  T  using  a  high-sensitivity  assay  (HS-CTnT)  and  coronary  calciﬁcation
using electron-beam  dual-source  computed  tomography.
Results:  The  average  ﬁbrinogen  concentration  increased  by  5.1%  (s.d.  =  7.3)  in  response  to
stress and  then  tended  to  return  to  baseline  values.  People  with  higher  baseline  ﬁbrinogen
values had  smaller  increases  (blunted  responses)  following  the  stress  task  (P  =  0.001),  and  peo-
ple with  higher  stress  responses  showed  better  recovery  (P  <  0.001).  In  unadjusted  analyses,
higher baseline  ﬁbrinogen  was  associated  with  higher  chances  of  having  detectable  HS-CTnT
(P =  0.072)  but,  conversely,  higher  ﬁbrinogen  response  was  associated  with  lower  chances  of
having detectable  HS-CTnT  (P  =  0.007).  The  adjustment  for  clinical,  inﬂammatory,  and  haemo-
static factors,  as  well  as  for  coronary  calciﬁcation  eliminated  the  effect  of  baseline  ﬁbrinogen,
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whereas  the  negative  association  between  ﬁbrinogen  response  and  HS-CTnT  remained  robust:
the odds  of  detectable  HS-CTnT  halved  for  each  10%  increase  in  ﬁbrinogen  concentration  due  to
stress (OR  =  0.49,  P  =  0.007,  95%  CI  =  0.30—0.82).
Conclusions:  Greater  ﬁbrinogen  responses  to  mental  stress  are  associated  with  lower  likelihood  of
detectable  high-sensitivity  troponin  T  plasma  concentration.  A  more  dynamic  ﬁbrinogen  response
appears to  be  advantageous  for  cardiovascular  health.
© 2015  The  Authors.  Published  by  Elsevier  Ltd.  This  is  an  open  access  article  under  the  CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Mental  stress  is  a  recognized  risk  factor  for  cardiovascular
disease  (CVD)  in  acute  conditions,  when  sudden  stressful
events  trigger  acute  CVD  events,  as  well  as  in  chronic  con-
ditions,  when  poor  adaptation  to  recurrent  daily  stressors
produces  a  pathophysiological  substratum  for  CVD  (Brotman
et  al.,  2007;  Steptoe  and  Kivimäki,  2012;  Surtees  et  al.,
2008).  Although  the  mechanisms  underlying  these  associa-
tions  have  not  been  completely  clariﬁed,  proinﬂammatory
factors,  cortisol  levels,  heart  rate  variability,  and  haemo-
static  processes  have  been  identiﬁed  as  key  mediators
(Dimsdale,  2008;  Lazzarino  et  al.,  2013;  Steptoe  and  Vögele,
1991).
Fibrinogen  is  a  plasma  protein  produced  by  the  liver
and  is  a  major  coagulation  factor.  It  is  a  positive  acute-
phase  reactant  protein,  i.e.  its  concentration  increases  with
inﬂammation,  and  it  is  traditionally  considered  as  a  risk
factor  for  CVD  because  it  promotes  formation  of  thrombus
(Lowe  et  al.,  2004;  Stulnig,  2013).
A  number  of  studies  have  found  positive  associations
between  mental  stress  and  plasma  ﬁbrinogen  concentration
(Brunner  et  al.,  1996;  Kittel  et  al.,  2002;  Steptoe  et  al.,
2003,  2004;  Von  Känel  et  al.,  2001;  Wirtz  et  al.,  2008,  2009).
These  include  large-scale  population  surveys  linking  single
measurements  of  plasma  ﬁbrinogen  with  questionnaire-
based  self-reported  levels  of  chronic  stress,  and  more
focused  psychophysiological  studies  that  have  measured
ﬁbrinogen  secretion  in  response  to  acute  mental  stress  in
laboratory-based  experimental  settings.  Regardless  of  the
study  design  and  the  reference  population,  higher  stress
was  associated  with  higher  ﬁbrinogen  plasma  concentration
(Brunner  et  al.,  1996;  Kittel  et  al.,  2002;  Steptoe  et  al.,
2003,  2004;  Von  Känel  et  al.,  2001;  Wirtz  et  al.,  2008,  2009).
The  pathway  linking  mental  stress,  ﬁbrinogen,  and  CVD
might  therefore  appear  to  be  deﬁned:  the  greater  the  stress
(or  poor  adaptation  to  stress),  the  higher  the  ﬁbrinogen,  and
the  greater  the  occurrence  of  CVD  (Austin  et  al.,  2013).
Nevertheless  this  causal  sequence  has  not  been  com-
pletely  disentangled  because  the  three  components  have
never  been  studied  together  in  a  single  framework.  Instead,
the  current  literature  is  made  of  two  separate  groups  of
studies:  one  considering  heightened  ﬁbrinogen  as  a func-
tion  of  mental  stress,  and  another  set  considering  it  as  a
risk  factor  for  CVD.  This  separation  inevitably  dictates  a
monophasic  approach  to  a  phenomenon  which  may  rather
be  better  described  within  an  integrated  multiphasic  frame-
work  due  to  the  complex  dynamics  of  ﬁbrinogen  metabolism
and  of  coagulation  pathways  in  general.
The  notion  of  allostasis  has  drawn  attention  to  the  com-
plex  system  of  neuroendocrine  responses  to  environmental
challenges  that  is  characteristic  of  living  organisms.  It  has
been  conceptualized  as  the  process  through  which  orga-
nisms  actively  adjust  to  both  predictable  and  unpredictable
external  events  through  the  anabolism  and  catabolism  of
mediators,  i.e.  the  way  in  which  they  maintain  stabil-
ity  through  change  (McEwen  and  Wingﬁeld,  2003).  From
this  perspective,  serious  pathophysiology  may  occur  when
chronic  overload  resulting  from  sustained  stress  stimulates
prolonged  allostatic  actions  that  in  the  long  term  lose
their  effectiveness  and  ability  to  respond  (McEwen  and
Wingﬁeld,  2010).  The  allostatic  model  suggests  that  sus-
tained  load  is  characterized  by  changes  in  the  morphology
of  responses  that  are  manifest  in  chronically  heightened
basal  levels,  inadequate  biological  responses  (blunted  stress
reactivity),  and  impaired  post-stress  recovery  (McEwen,
1998).
We  have  recently  used  cardiac  Troponin  T  (CTnT)  as
a  marker  of  CVD  risk  in  conjunction  with  mental  stress
(Lazzarino  et  al.,  2013).  CTnT  is  a  plasma  protein  routinely
tested  for  the  diagnosis  of  acute  myocardial  infarction  (AMI),
since  it  is  a  marker  of  myocardial  cell  damage  (Thygesen
et  al.,  2007).  In  clinical  settings,  CTnT  is  measured  using
standard  assays  that  have  a  lower  detection  limit  of  10  ng/L
(Wallace  et  al.,  2006) and  a  diagnostic  threshold  of  35  ng/L
(Thygesen  et  al.,  2007;  Wallace  et  al.,  2006).  However,
high-sensitivity  assays  have  recently  been  developed  (HS-
CTnT)  with  a lower  detection  limit  of  3  ng/L  (Collinson,
2011;  Collinson  et  al.,  2012;  Giannitsis  et  al.,  2010).  In
healthy  people  not  fulﬁlling  any  diagnostic  criterion  for  AMI,
greater  HS-CTnT  is  associated  with  greater  incidence  of  AMI,
other  structural  and  functional  heart  diseases,  cardiovascu-
lar  mortality,  and  all-cause  mortality,  and  can  be  therefore
considered  the  most  proximal  sentinel  marker  of  heart  dis-
ease  (deFilippi  et  al.,  2010;  De  Lemos  et  al.,  2010).  We  have
shown  that  dysregulated  response  to  mental  stress  —  marked
using  salivary  cortisol  release  in  response  to  mental  stress
—  was  associated  with  detectable  plasma  levels  of  HS-CTnT.
If  HS-CTnT  is  a  good  marker  of  CVD  risk  linked  to  mental
stress,  it  may  therefore  be  a  valid  outcome  in  the  study  of
ﬁbrinogen  release  in  response  to  mental  stress  (Lazzarino
et  al.,  2013).
Fibrinogen  can  be  considered  as  an  important  compo-
nent  of  the  network  of  mediators  relevant  to  cardiovascular
allostasis  because  of  its  association  with  both  mental  stress
and  CVD,  and  because  of  its  role  within  the  coagula-
tion  system  and  in  inﬂammation.  Therefore  we  aimed  to
study  the  associations  between  basal  ﬁbrinogen,  ﬁbrinogen
secretion  in  response  to  stress  tasks,  ﬁbrinogen  recov-
ery  from  stress,  and  high-sensitivity  cardiac  troponin  T
(as  a  marker  of  CVD  risk)  within  a  single  integrated
framework.
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2. Methods
2.1.  Study  design
Our  study  involved  participants  drawn  from  the  Whitehall
II  epidemiological  cohort  (Marmot  et  al.,  1991)  for  psy-
chophysiological  testing  between  2006  and  2008  (Hamer
et  al.,  2010).  The  criteria  for  entry  into  the  study  included
no  history  or  objective  signs  of  clinical  or  subclinical  CVD,
no  previous  diagnosis  or  treatment  for  hypertension,  inﬂam-
matory  diseases,  allergies,  or  kidney  disease.  CVD  was
deﬁned  as  prior  myocardial  infarction,  stable  or  unstable
angina,  revascularization  procedure,  heart  failure,  transient
ischaemic  attack,  stroke,  or  electrocardiographic  abnor-
malities  (resting  12-lead  electrocardiograms  were  taken).
This  information  was  conﬁrmed  by  a  telephone  interview
and  veriﬁed  from  clinical  data  collected  from  the  previ-
ous  seven  phases  of  the  Whitehall  II  study.  Volunteers  were
of  white  European  origin,  aged  53—76  years,  and  56.5%
were  in  full-time  employment.  Selection  was  stratiﬁed  by
grade  of  employment  (current  or  most  recent)  to  include
higher  and  lower  socioeconomic  status  participants.  From
the  initially  invited  participants  (n  =  1169),  27.6%  were  not
eligible  (mainly  because  of  prescribed  medications)  and
25.9%  declined  to  take  part.  Participants  were  prohibited
from  using  any  anti-histamine  or  anti-inﬂammatory  medi-
cation  7  days  before  testing  and  were  rescheduled  if  they
reported  colds  or  other  infections  on  the  day  of  testing.
Participants  gave  full  informed  consent  to  participate  in
the  study  and  ethical  approval  was  obtained  from  the  UCLH
committee  on  the  Ethics  of  Human  Research.
2.2.  Data  collection
We  carried  out  psychophysiological  stress  testing  in  either
the  morning  or  afternoon  in  a  light  temperature-controlled
laboratory.  This  procedure  was  based  on  a  protocol  pre-
viously  used  in  this  laboratory  (Steptoe  et  al.,  2002).
Participants  were  instructed  to  refrain  from  drinking  caf-
feinated  beverages  or  smoking  for  at  least  2  h  before  the
study  and  not  to  have  performed  vigorous  physical  activ-
ity  or  consumed  alcohol  the  previous  evening.  Venipuncture
was  performed  using  a  butterﬂy  needle  that  was  inserted
before  the  beginning  of  the  session  and  removed  after  the
end  of  it.  After  a  30  min  rest  period  from  needle  insertion,
baseline  blood  pressure  (using  an  automated  UA-779  digi-
tal  monitor)  was  taken  as  well  as  saliva  and  blood  samples.
Two  behavioural  tasks,  designed  to  induce  mental  stress,
were  then  administered  in  random  order.  The  tasks  were  a
computerized  version  of  the  Stroop  task  and  mirror  tracing,
both  of  which  have  been  used  extensively  in  psychophys-
iological  research  (Steptoe  et  al.,  2002).  The  tasks  each
lasted  for  5  min.  Saliva  and  blood  samples  were  then  col-
lected  immediately  and  at  45  min  after  the  tasks.  The  saliva
samples  were  collected  using  Salivettes  (Sarsted,  Leicester,
UK),  which  were  stored  at  −30 ◦C  until  analysis.  Levels  of
cortisol  were  assessed  using  a  time  resolved  immunoassay
with  ﬂuorescence  detection,  at  the  University  of  Dresden.
The  intra-  and  inter-assay  coefﬁcients  of  variation  were  less
than  8%.  We  assayed  plasma  IL-6  using  a  Quantikine® high
sensitivity  two-site  enzyme-linked  immunosorbent  assay
(ELISA)  from  R&D  Systems  (Oxford,  UK).  The  sensitivity  of
the  assay  ranged  from  0.016  to  0.110  pg/ml  and  the  intra
and  inter  assay  coefﬁcients  of  variation  (CV)  were  7.3%
and  7.7%  respectively.  C-reactive  protein  (CRP)  was  mea-
sured  using  high-sensitivity  ELISA  (R&D  Systems,  Oxford,
UK;  CVs  <8%).  Monocyte  chemotactic  protein-1  (MCP-1)  was
assayed  using  the  Magnetic  Luminex  Performance  Assay
Human  CCL2/MCP-1  multiplexed  IL-1RA  kit  (R&D  Systems®)
read  on  a  Luminex  200  (Bio-Rad®) with  a  CV  <8%.  Von
Willebrand  factor  (vWF)  was  determined  using  a  double
sandwiched  antibody  enzyme-linked  immunoassay  (Dako-
Cytomation  Ltd.,  Cambridge,  UK;  CVs  <5%)  and  ﬁbrinogen
by  an  automated  Clauss  assay  in  a  MDA-180  coagulometer
(Organon  Teknika,  Cambridge,  UK)  using  the  manufacturer’s
reagents  and  the  International  ﬁbrinogen  standard  (inter-
and  intra-individual  CV  is  8%)  (Gaffney  and  Wong,  1992).
We  measured  cardiac  troponin  T  plasma  concentration  at
75  min  after  the  end  of  the  mental  stress  task  using  a  highly
sensitive  assay  on  an  automated  platform  (Elecsys  2010  Tro-
ponin  T  hs  STAT,  Roche  Diagnostics).  The  lower  detection
limit  was  3  ng/L  with  a  reported  99th  percentile  value  in
apparently  healthy  individuals  of  13.5  ng/L,  at  which  the
inter-  and  intra-individual  CV  is  9%,  conﬁrmed  by  in-house
studies  (Collinson,  2011;  Collinson  et  al.,  2012;  Giannitsis
et  al.,  2010).
We  assessed  coronary  artery  calciﬁcation  (CAC)  in  sep-
arate  sessions  using  electron  beam  computed  tomography
(GE  Imatron  C-150,  San  Francisco,  CA,  USA)  as  previously
described  (Anand  et  al.,  2007).  In  brief,  40  contiguous  3  mm
slices  were  obtained  during  a  single  breath-hold  starting  at
the  carina  and  proceeding  to  the  level  of  the  diaphragm.
Scan  time  was  100  ms/slice,  synchronized  to  40%  of  the
R—R  interval.  Agatston  and  volumetric  calcium  scores  were
calculated  to  quantify  the  extent  of  CAC  by  a  single  expe-
rienced  investigator  blinded  to  the  psychophysiological  and
clinical  data  on  an  Aquarius  workstation  (TeraRecon  Inc.,
San  Mateo,  CA,  USA).  Since  calciﬁed  volume  was  very  highly
correlated  with  Agatston  score  (Spearman’s  rho  =  0.99),  we
present  data  for  Agatston  score  only.
Participants  reported  current  smoking  levels,  weekly
alcohol  intake  (units  per  week),  employment  grade  (as
a  marker  of  social  position),  and  hours  of  moderate
or  vigorous  physical  activity  per  week.  We  measured
height  and  weight  in  light  clothing  for  the  calcula-
tion  of  body  mass  index  (BMI)  as  kg/m2.  Fasting  blood
samples  were  taken  during  a  separate  clinical  assess-
ment.  Total  and  high-density  lipoprotein  (HDL)  cholesterol
and  triglycerides  were  measured  within  72  h  in  serum
stored  at  4 ◦C  using  enzymatic  colorimetric  methods.  Low-
density  lipoprotein  (LDL)  cholesterol  was  derived  using  the
Friedewald  equation  (Warnick  et  al.,  1990).  Glucose  homeo-
stasis  was  assessed  from  glycated  haemoglobin  (HbA1C)
concentration,  assayed  using  boronate  afﬁnity  chromatog-
raphy,  a  combination  of  boronate  afﬁnity  and  liquid
chromatography.
2.3.  Data  analysis
We  checked  the  data  for  missing,  inconsistent,  and  duplicate
information,  as  well  as  normality  and  digit  preference  for
continuous  variables.
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We  quantiﬁed  the  ﬁbrinogen  response  to  stress  as  the  pro-
portional  increase  in  ﬁbrinogen  plasma  concentration  after
the  stress  task  ([immediate-post-task  minus  pre-task]/pre-
task).  Similarly,  we  quantiﬁed  the  ﬁbrinogen  recovery
from  stress  as  the  proportional  decrease  in  ﬁbrinogen
after  the  stress  task  ([immediate-post-task  minus  45  min-
post-task]/immediate-post-task).  Agatston  CAC  score  had
a  right-skewed  distribution  and  for  some  analyses  was
transformed  into  an  ordered  categorical  variable  with  four
categories  (cut-offs  at  0,  100,  and  400).
We  conducted  bivariate  analyses  and  calculated  P  values
using  the  likelihood  ratio  test.  We  then  used  three  separate
sets  of  multiple  logistic  regression  models  to  examine  the
association  between  detectable  HS-CTnT  (outcome)  with
either  baseline  ﬁbrinogen  or  ﬁbrinogen  stress  response  or
ﬁbrinogen  recovery  (alternative  exposure  variables).  Fibrin-
ogen  response  or  recovery  may  differ  according  to  baseline
levels,  so  this  parameter  was  included  as  a  covariate  when
they  were  the  exposure  variable.  We  also  adjusted  for  demo-
graphics  such  as  age,  gender,  and  employment  grade,  and
for  health  behaviours  such  as  smoking  and  alcohol  intake
because  they  are  related  to  CVD  and  may  confound  the
association  between  ﬁbrinogen  and  CVD.  We  also  took  into
account  clinical  variables  that  are  known  to  be  linked  with
CVD  such  as  BMI,  blood  pressure,  glycated  haemoglobin
(HbA1c),  triglycerides,  LDL,  and  total  cholesterol/HDL  ratio.
Moreover,  we  adjusted  for  baseline  and  response  values  of
circulating  markers  of  inﬂammation  and  endothelial  dys-
function  such  as  CRP,  cortisol,  IL-6,  vWF,  and  MCP-1  to
account  for  vascular  inﬂammation  and  endothelial  dysfunc-
tion.  Finally,  we  adjusted  for  Agatston  CAC  score  to  examine
whether  the  association  between  ﬁbrinogen  and  HS-CTnT
was  independent  of  underlying  coronary  atherosclerosis.  We
evaluated  the  extent  of  multicollinearity  among  covariates
by  computing  one-to-one  correlation  coefﬁcients  and  by
examining  variance  inﬂation  factors  (VIF)  (‘‘Regression  with
Stata  Web  Book:  Chapter  2  —  Regression  Diagnostics,’’  n.d.).
We  performed  several  sensitivity  analyses:  we  considered
stress  response  and  recovery  as  absolute  changes  in  ﬁbrin-
ogen  concentration  rather  than  relative  (the  Spearman’s
rho  coefﬁcient  of  correlation  between  the  two  approaches
was  0.98  for  stress  response  and  0.99  for  stress  recovery);
we  adjusted  for  CAC  using  a  continuous  natural  loga-
rithmic  scale  (before  the  log-transformation,  zero  values
were  recoded  to  values  equal  to  the  half  of  the  small-
est  value  in  the  dataset);  we  repeated  the  analyses  of
stress  responses  and  recovery  without  adjusting  for  baseline
values  of  ﬁbrinogen;  we  restricted  the  analysis  to  partic-
ipants  with  no  CAC;  after  having  ﬁtted  the  ﬁnal  models
we  carried  out  a  backward  stepwise  estimation  to  elim-
inate  unnecessary  covariates  (P  value  for  retention  =  0.05
or  less);  given  the  elevated  number  of  undetectable  val-
ues  for  HS-CTnT,  we  have  transformed  that  measure  into
an  ordered  categorical  variable  scoring  zero  for  unde-
tectable  levels  (<3  ng/L),  one  for  detectable  levels  up  to
5.63  ng/L  (median  value  for  detectable  levels),  and  two  for
detectable  levels  above  5.63  ng/L,  and  used  multinomial
logistic  regression  and  linear  regression  instead  of  logistic
regression.
Additional  analyses  involved  blood  pressure  response  and
heart  rate  response  as  possible  determinants  of  HS-CTnT
detection.
3. Results
A  total  of  543  people  participated  in  the  study,  but  52  (9.6%)
had  missing  information  for  HS-CTnT  or  ﬁbrinogen  due  to
insufﬁcient  blood  samples  and  were  therefore  removed.
The  ﬁnal  analytic  sample  comprised  491  disease-free  par-
ticipants  aged  62.9  years  on  average  (standard  deviation
[s.d.]  =  5.7)  of  whom  54.1%  were  men.  The  excluded  par-
ticipants  did  not  differ  signiﬁcantly  from  the  main  sample  in
any  covariates.  The  mean  ﬁbrinogen  concentration  at  base-
line  was  314.1  mg/dL  (s.d.  =  61.6),  and  on  average  increased
to  the  value  of  330.1  mg/dL  (s.d.  =  65.9)  in  response  to
the  stress  task,  and  then  decreased  during  the  recov-
ery  period  to  the  mean  value  of  321.9  mg/dL  (s.d.  =  65.0)
measured  at  45  min  post  task.  There  was  considerable
inter-individual  variation  in  ﬁbrinogen  response  and  recov-
ery:  the  average  ﬁbrinogen  increase  in  response  to  the
stress  tasks  was  5.1%  (s.d.  =  7.3)  with  values  ranging  from
−30.5%  to  +57.6%  (therefore  for  some  individuals  ﬁbrin-
ogen  plasma  concentration  decreased  in  response  to  the
stress  tasks),  and  the  average  decrease  in  ﬁbrinogen  dur-
ing  the  recovery  period  was  2.3%  (s.d.  =  7.8)  with  values
ranging  from  −68.5%  to  +23.1%  (therefore  for  some  indi-
viduals  ﬁbrinogen  plasma  concentration  increased  during
the  resting  period).  The  prevalence  of  detectable  levels  of
HS-CTnT  concentrations  was  17.1%  (95%  conﬁdence  interval
[CI]  =  13.8%—20.5%).
In unadjusted  analysis,  people  with  detectable  levels  of
HS-CTnT  appeared  to  have  on  average  higher  levels  of  base-
line  ﬁbrinogen  and  ﬂatter  proﬁle  to  the  mental  stress  test,
i.e.  blunted  response  and  slower  recovery  (Fig.  1).
Table  1  describes  the  sample  according  to  baseline  ﬁbrin-
ogen.  People  with  higher  ﬁbrinogen  tended  to  be  older,  of
lower  socio-economic  status  as  deﬁned  by  grade  of  employ-
ment,  were  more  likely  to  be  female,  smoker,  and  low
alcohol  consumers,  and  also  tended  to  have  higher  levels  of
clinical  and  inﬂammatory  factors  such  as  BMI,  blood  pres-
sure,  glycated  haemoglobin,  LDL,  total  cholesterol,  CRP,
Figure  1  Mean  concentration  of  ﬁbrinogen  in  the  peripheral
blood plasma,  measured  at  baseline  (before  the  stress  task),
immediately  after  the  stress  task  (response  values),  and  follow-
ing a  45  min  rest  period  (recovery)  in  people  with  (n  =  407)  and
without  (n  =  84)  detectable  levels  of  HS-CTnT  peripheral  blood
plasma  concentration,  for  491  disease-free  participants  drawn
from the  Whitehall  II  epidemiological  cohort  between  2006  and
2008 in  United  Kingdom.
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Table  1  Characteristics  of  the  study  sample  by  tertiles  of  plasma  ﬁbrinogen  concentration  measured  at  baseline,  for  491
disease-free participants  drawn  from  the  Whitehall  II  epidemiological  cohort  between  2006  and  2008  in  United  Kingdom.
Factor  and  category  Tertiles  of  plasma  ﬁbrinogen  at  baseline  P
Lowest  Medium  Highest
Age  (mean  years  ±  s.d.)  62.4  ±5.2  62.9  ±5.6  63.6  ±6.2  0.001
Male (%)  66.1  50.6  46.6  <0.001
Latest grade  of  employment  (%)
Higher  42.5 40.7 33.5 <0.001
Intermediate  42.5 39.0 35.8
Lower 14.9 20.3 30.7
Current  smoker  (%)  3.4  4.1  9.1  <0.001
Alcohol consumption  (%)
No alcohol  9.8  15.7  21.6 0.005
Below recommended  levels  74.7  73.3  65.3
Above recommended  levels 15.5 11.0 13.1
Hours  of  physical  activity  per  week  (%)
<1 h 22.1 24.1 24.4 0.559
1—4  h  29.7  36.7  30.2
5—7 h  23.8  21.7  22.7
>7 h  24.4  17.5  22.7
Body mass  index  (mean  kg/m2 ±  s.d.)  24.6  ±3.2  25.6  ±3.8  27.2  ±4.3  <0.001
Systolic blood  pressure  (mean  mmHg  ±  s.d.)  127.0  ±14.7  130.4  ±16.4  129.6  ±16.3  0.123
Diastolic blood  pressure  (mean  mmHg  ±  s.d.)  68.2  ±8.2  70.5  ±8.7  70.5  ±9.2  0.015
Glycated haemoglobin  (mean  %  ±  s.d.)  5.4  ±0.6  5.5  ±0.4  5.5  ±0.4  0.001
Triglycerides  (median  g/L  ±  IQR)  1.2  ±0.8  1.2  ±1.0  1.2  ±0.7  0.761
HDL (mean  mmol/L  ±  s.d.)  1.7  ±0.5  1.7  ±0.5  1.7  ±0.5  0.661
LDL (mean  mmol/L  ±  s.d.)  2.9  ±0.8  3.0  ±0.8  3.1  ±1.0  0.013
Total cholesterol  (mean  mmol/L  ±  s.d.)  5.2  ±0.9  5.3  ±0.9  5.4  ±1.0  0.043
Total cholesterol/HDL  ratio  (mean  ±  s.d)  3.3  ±1.0  3.4  ±1.1  3.5  ±1.2  0.074
C-reactive protein  (median  mg/L  ±  IQR)  0.6  ±0.7  1.0  ±1.1  1.7  ±2.2  <0.001
Salivary cortisol  (mean  nmol/L  ±  s.d.)  6.8  ±5.1  6.4  ±3.8  6.3  ±4.0  0.566
IL-6 (median  pg/ml  ±  IQR)  0.9  ±0.5  1.1  ±0.8  1.4  ±1.1  <0.001
Von Willebrand  factor  (mean  %  ±  s.d.)  96.3  ±35.3  102.9  ±36.9  114.4  ±44.1  0.001
MCP-1 (median  pg/mL  ±  IQR)  134.8  ±58.7  138.4  ±54.5  141.8  ±61.6  0.492
Fibrinogen (mean  mg/dL  ±  s.d.)  251.8  ±24.7  308.7  ±13.2  380.9  ±46.5
Salivary cortisol  response  (mean  %
increase  ±  s.d.)
15.1  ±65.4  16.7  ±53.5  17.7  ±60.2  0.520
IL-6 response  (mean  %  increase  ±  s.d.) 46.2 ±74.3  34.7  ±44.9  35.5  ±59.8  0.212
Von Willebrand  factor  response  (mean  %
increase  ±  s.d.)
7.1  ±22.6  4.3  ±20.7  3.7  ±18.5  0.554
MCP-1 response  (mean  %  increase  ±  s.d.)  8.6  ±24.5  9.2  ±23.8  5.8  ±20.6  0.325
Fibrinogen response  (mean  %  increase  ±  s.d.)  6.6  ±8.0  4.5  ±7.2  4.3  ±6.5  0.001
Fibrinogen recovery  (mean  %  decrease  ±  s.d.)  2.6  ±8.5  2.3  ±7.6  2.0  ±7.5  0.363
Agatston coronary  calcium  score
(%)
None  40.8  44.8  44.3 0.513
<100 35.6  32.6  29.5
<400 15.5  15.7  12.5
400+ 8.0  7.0  13.6
HS-CTnT detectable  (>3  ng/L)  (%)  13.9  17.4  19.6  0.072
HS-CTnT concentration  if  detectable  (geom.
mean  ng/L  ±  s.d.)
6.7  ±1.8  6.0  ±1.5  6.7  ±2.0  0.578
P values were computed using the likelihood ratio test. All variables were measured at baseline with the exception of response variables
(calculated as the proportional increase from baseline to immediately post task) and ﬁbrinogen recovery (calculated as the proportional
decrease from immediate post task to 45 min post task). HS-CTnT was measured at 75 min post task. Tertiles of plasma ﬁbrinogen at
baseline (mg/dL): lowest = from 166 to 283; medium = from 284 to 330; highest = from 331 to 573. IQR = interquartile range.
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Table  2  Characteristics  of  the  study  sample  by  tertiles  of  plasma  ﬁbrinogen  response  to  mental  stress  task  (proportional  increase
from immediate  pre  task  to  immediate  post  task),  for  491  disease-free  participants  drawn  from  the  Whitehall  II  epidemiological
cohort between  2006  and  2008  in  United  Kingdom.
Factor  and  category  Tertiles  of  plasma  ﬁbrinogen  response
(proportional  increase)
P  value
Lowest  Medium  Highest
Age  (mean  years  ±  s.d.)  63.2  ±6.0  62.8  ±5.5  62.9  ±5.5  0.279
Male (%)  55.3  53.2  55.0  0.813
Latest grade  of  employment  (%)
Higher  38.8  39.2  38.0 0.383
Intermediate  39.4  36.3  40.9
Lower 21.8 24.6  21.1
Current  smoker  (%)  5.9  4.7  6.4  0.470
Alcohol consumption  (%)
No alcohol  17.6  14.6  15.2 0.832
Below recommended  levels  65.9  74.3  73.1
Above recommended  levels 16.5  11.1  11.7
Hours of  physical  activity  per  week  (%)
<1 h 24.6  20.4  25.9 0.793
1—4 h 38.3 29.3  28.3
5—7 h 19.8 25.1 23.5
>7  h 17.4 25.1  22.3
Body mass  index  (mean  kg/m2 ±  s.d.) 26.3 ±3.7 25.7  ±4.3  25.5  ±3.7  0.294
Systolic blood  pressure  (mean  mmHg  ±  s.d.) 129.7 ±15.4  128.8  ±17.6  128.8  ±14.8  0.565
Diastolic blood  pressure  (mean  mmHg  ±  s.d.) 70.7 ±8.6 69.3  ±8.3  69.3  ±9.2  0.157
Glycated haemoglobin  (mean  %  ±  s.d.) 5.5 ±0.7 5.5 ±0.3  5.4  ±0.4  0.072
Triglycerides  (median  g/L  ±  IQR) 1.3 ±0.9 1.1 ±0.8 1.2  ±0.8  0.480
HDL (mean  mmol/L  ±  s.d.) 1.6 ±0.5  1.7  ±0.4  1.7  ±0.5  0.947
LDL (mean  mmol/L  ±  s.d.)  3.1  ±0.9  2.9  ±0.8  3.0  ±0.8  0.253
Total cholesterol  (mean  mmol/L  ±  s.d.)  5.4  ±1.0  5.2  ±0.8  5.3  ±0.9  0.130
Total cholesterol/HDL  ratio  (mean  ±  s.d)  3.6  ±1.2  3.2  ±0.9  3.4  ±1.1  0.221
C-reactive protein  (median  mg/L  ±  IQR)  1.0  ±1.3  1.1  ±1.5  0.9  ±1.2  0.683
Salivary cortisol  (mean  nmol/L  ±  s.d.)  6.2  ±3.7  6.8  ±4.8  6.3  ±3.7  0.935
IL-6 (median  pg/ml  ±  IQR)  1.2  ±0.7  1.1  ±0.9  1.1  ±0.7  0.095
Von Willebrand  factor  (mean  %  ±  s.d.)  105.6  ±39.9  107.4  ±40.0  100.1  ±38.2  0.264
MCP-1 (median  pg/mL  ±  IQR)  143.5  ±59.3  138.5  ±57.4  128.7  ±59.4  0.040
Fibrinogen (mean  mg/dL  ±  s.d.)  321.6  ±57.6  320.8  ±59.8  302.0  ±65.8  0.001
Salivary cortisol  response  (mean  %
increase  ±  s.d.)
16.1  ±54.2  17.7  ±60.3  14.9  ±65.3  0.711
IL-6 response  (mean  %  increase  ±  s.d.)  40.1  ±60.7  35.1  ±53.5  41.3  ±68.8  0.329
Von Willebrand  factor  response  (mean  %
increase  ±  s.d.)
2.8  ±22.2  3.9  ±19.4  8.4  ±19.8  <0.001
MCP-1 response  (mean  %  increase  ±  s.d.)  9.4  ±24.3  5.9  ±19.8  7.7  ±24.0  0.014
Fibrinogen response  (mean  %  increase  ±  s.d.)  −1.9  ±5.1  5.0  ±1.4  12.2  ±5.8
Fibrinogen  recovery  (mean  %  decrease  ±  s.d.)  −1.7  ±10.5  3.2  ±4.6  5.2  ±5.4  <0.001
Agatston coronary  calcium  score  (%)
None  41.2  46.2  43.9 0.340
<100 32.4  31.6  32.7
<400 15.3  12.9  15.8
400+ 11.2  9.4  7.6
HS-CTnT  detectable  (>3  ng/L)  (%)  21.6  19.2  10.5  0.007
HS-CTnT concentration  if  detectable  (geom.
mean ng/L  ±  s.d.)
6.7  ±1.6  6.7  ±2.0  5.5  ±1.5  0.393
P values were computed using the likelihood ratio test. All variables were measured at baseline with the exception of response variables
(calculated as the proportional increase from baseline to immediately post task) and ﬁbrinogen recovery (calculated as the proportional
decrease from immediate post task to 45 min post task). HS-CTnT was measured at 75 min post task. Tertiles of plasma ﬁbrinogen response
(%): lowest = from −30.5 to 2.6; medium = from 2.7 to 7.4; highest = from 7.4 to 57.6.
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Table  3  Characteristic  of  the  study  sample  by  tertiles  of  plasma  ﬁbrinogen  recovery  to  mental  stress  task  (proportional  decrease
from immediate  post  task  to  45  min  post  task),  for  491  disease-free  participants  drawn  from  the  Whitehall  II  epidemiological
cohort between  2006  and  2008  in  United  Kingdom.
Factor  and  category  Tertiles  of  plasma  ﬁbrinogen  recovery
(proportional  decrease)
P  value
Lowest  Medium  Highest
Age  (mean  years  ±  s.d.)  63.9  ±6.1  62.8  ±5.7  62.3  ±5.1  0.115
Male (%)  51.5  55.6  56.4  0.881
Latest grade  of  employment  (%)
Higher  41.5  39.2  35.5 0.428
Intermediate  39.2  33.9  43.0
Lower 19.3 26.9  21.5
Current  smoker  (%)  6.4  7.0  3.5  0.085
Alcohol consumption  (%)
No alcohol  15.2  17.0  15.7 0.875
Below recommended  levels  70.2  72.5  70.3
Above recommended  levels 14.6  10.5  14.0
Hours of  physical  activity  per  week  (%)
<1 h 25.4  23.8  21.2 0.423
1—4 h 32.5 33.9  29.1
5—7 h 20.1 22.0 26.7
>7  h 21.9 20.2  23.0
Body mass  index  (mean  kg/m2 ±  s.d.) 26.0 ±4.1 25.9  ±3.9  25.5  ±3.8  0.357
Systolic blood  pressure  (mean  mmHg  ±  s.d.) 128.6 ±15.2  128.8  ±16.2  129.9  ±16.5  0.934
Diastolic blood  pressure  (mean  mmHg  ±  s.d.) 69.4 ±7.9 69.5  ±8.2  70.3  ±9.9  0.917
Glycated haemoglobin  (mean  %  ±  s.d.) 5.5 ±0.6 5.5 ±0.4  5.4  ±0.4  0.895
Triglycerides  (median  g/L  ±  IQR) 1.3 ±0.7 1.2 ±0.8 1.0  ±0.9  0.100
HDL (mean  mmol/L  ±  s.d.) 1.7 ±0.5  1.7  ±0.5  1.6  ±0.4  0.325
LDL (mean  mmol/L  ±  s.d.)  3.1  ±1.0  2.9  ±0.7  3.0  ±0.8  0.705
Total cholesterol  (mean  mmol/L  ±  s.d.)  5.4  ±1.0  5.2  ±0.8  5.3  ±0.9  0.142
Total cholesterol/HDL  ratio  (mean  ±  s.d)  3.5  ±1.2  3.4  ±1.1  3.4  ±1.0  0.825
C-reactive protein  (median  mg/L  ±  IQR)  1.1  ±1.3  1.1  ±1.6  0.9  ±1.1  0.178
Salivary cortisol  (mean  nmol/L  ±  s.d.)  6.7  ±4.4  6.5  ±4.4  6.1  ±3.5  0.586
IL-6 (median  pg/ml  ±  IQR)  1.2  ±0.8  1.2  ±0.9  1.0  ±0.7  0.206
Von Willebrand  factor  (mean  %  ±  s.d.)  105.8  ±38.0  105.9  ±38.1  101.0  ±42.3  0.230
MCP-1 (median  pg/mL  ±  IQR)  145.3  ±55.2  133.5  ±51.8  135.9  ±63.2  0.015
Fibrinogen (mean  mg/dL  ±  s.d.)  316.5  ±60.7  323.3  ±63.7  304.6  ±59.6  0.363
Salivary cortisol  response  (mean  %
increase  ±  s.d.)
8.5  ±41.7  17.3  ±66.8  22.9  ±67.3  0.135
IL-6 response  (mean  %  increase  ±  s.d.)  3.2  ±16.1  2.4  ±14.1  0.9  ±12.4  0.011
Von Willebrand  factor  response  (mean  %
increase  ±  s.d.)
3.3  ±21.7  5.7  ±24.6  7.1  ±19.8  0.005
MCP-1 response  (mean  %  increase  ±  s.d.)  12.6  ±29.4  6.0  ±18.3  4.3  ±17.8  <0.001
Fibrinogen response  (mean  %  increase  ±  s.d.)  1.6  ±7.5  5.5  ±5.4  8.4  ±7.2  <0.001
Fibrinogen recovery  (mean  %  decrease  ±  s.d.)  −5.0  ±8.7  2.9  ±1.4  8.8  ±3.3
Agatston coronary  calcium  score  (%)
None  43.9  45.0  42.4 0.999
<100 31.0  33.9  31.4
<400 16.4  11.1  16.9
400+ 8.8  9.9  9.3
HS-CTnT  detectable  (>3  ng/L)  (%)  20.6  17.6  12.9  0.365
HS-CTnT concentration  if  detectable  (geom.
mean ng/L  ±  s.d.)
5.5  ±1.6  6.7  ±1.8  7.4  ±2.0  0.105
P values were computed using the likelihood ratio test. All variables were measured at baseline with the exception of response variables
(calculated as the proportional increase from baseline to immediately post task) and ﬁbrinogen recovery (calculated as the proportional
decrease from immediate post task to 45 min post task). HS-CTnT was measured at 75 min post task. Tertiles of plasma ﬁbrinogen recovery
(%): lowest = from −68.5 to 0.3; medium = from 0.4 to 5.2; highest = from 5.2 to 23.1.
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IL-6,  and  vWF.  Higher  levels  of  baseline  ﬁbrinogen  were
also  strongly  associated  with  smaller  increases  (blunted
responses)  in  ﬁbrinogen  after  the  mental  stress  tasks
(P  =  0.001)  and  were  marginally  associated  with  positive  HS-
CTnT  values  (P  =  0.072).
Table  2  shows  the  correlates  of  ﬁbrinogen  responses
to  mental  stress  tasks.  In  contrast  to  baseline,  ﬁbrinogen
responses  seemed  to  be  independent  from  age,  gender,
and  most  of  the  other  clinical  and  inﬂammatory  covariates.
Higher  responses  to  stress  were  strongly  associated  with  bet-
ter  recovery  (P  =  0.001)  and  with  lower  chances  of  testing
positive  for  HS-CTnT  (P  =  0.007).
The  correlates  of  individual  differences  in  post-stress
ﬁbrinogen  recovery  are  shown  in  Table  3.  Fibrinogen  recov-
ery  rates  appeared  to  be  independent  of  most  covariates,
with  the  exceptions  of  MCP-1,  IL-6,  and  vWf,  and  to  be
weakly  associated  with  HS-CTnT  (P  =  0.365).
Table  4  summarizes  the  results  from  the  logistic  regres-
sions  on  HS-CTnT.  The  marginally  signiﬁcant  positive
association  between  baseline  ﬁbrinogen  concentration  and
HS-CTnT  was  eliminated  after  the  adjustment  for  covari-
ates.  In  contrast,  the  negative  association  between  stress
response  and  detectable  HS-CTnT  remained  very  similar  to
the  crude  association  in  terms  of  both  effect  size  and  statis-
tical  signiﬁcance  after  adjustment  for  demographic  factors,
cardiovascular  risk  factors,  neuroendocrine  and  inﬂamma-
tory  variables,  and  extent  of  coronary  calciﬁcation:  the
odds  of  detectable  HS-CTnT  halved  for  each  10%  increase
in  ﬁbrinogen  response  to  stress  task  (odds  ratio  [OR]  =  0.49;
P  =  0.007;  95%  CI  =  0.30—0.82).
No  pair  of  covariates  had  a  correlation  coefﬁcient  >0.30,
with  the  following  exceptions:  systolic  and  diastolic  blood
pressure  (0.70);  LDL  and  total  cholesterol/HDL  ratio  (0.62);
triglycerides  and  total  cholesterol/HDL  ratio  (0.62);  CRP  and
BMI  (0.53);  CRP  and  baseline  IL-6  (0.45).  All  covariates  had
VIFs  <3.  The  exclusion  of  one  or  both  components  of  the
mentioned  pairs  of  covariates  did  not  change  the  results.  All
sensitivity  analyses  gave  similar  results  to  the  main  analyses.
The  additional  analyses  involving  blood  pressure  response
and  heart  rate  response  as  possible  determinants  of  HS-CTnT
detection,  gave  null  ﬁndings:  although  systolic  blood  pres-
sure  increased  on  average  by  35.7  mmHg  (s.d.  =  16.0)  due
to  the  stress  tests,  diastolic  blood  pressure  by  16.8  mmHg
(s.d.  =  7.5),  and  heart  rate  by  10.5  (s.d.  =  9.2)  beats  per
minute,  the  increase  in  those  parameters  was  not  associated
with  positive  values  of  HS-CTnT.
4. Discussion
This  study  conﬁrms  prior  evidence  showing  an  increase
in  plasma  ﬁbrinogen  in  response  to  mental  stress.  How-
ever,  in  contrast  with  the  notion  that  larger  ﬁbrinogen
stress  responses  may  be  pathogenic,  our  results  suggest  that
greater  increases  have  a  physiological  protective  role  for
cardiovascular  health  such  that  people  with  ﬂat  morphol-
ogy  of  reaction  to  mental  stress  seem  to  be  less  protected.
Among  the  three  phases,  i.e.  basal  ﬁbrinogen  levels,  stress
reactivity,  and  post-stress  recovery,  the  reactivity  seems  to
be  the  more  robust  marker  of  allostatic  adaptation,  showing
very  large  effect  size,  statistical  signiﬁcance,  and  indepen-
dence  from  covariates.
We  have  also  shown  that  a  sequence  of  two  brief
moderately  challenging  mental  stress  tasks,  which  are
speciﬁcally  designed  to  mimic  mild  every-day-life  stress-
ors,  can  inﬂuence  ﬁbrinogen  release  into  the  blood  stream
very  efﬁciently  for  some  individuals  and  less  efﬁciently
for  others,  even  if  they  are  drawn  from  a  well-deﬁned,
low-risk,  disease-free  population.  It  follows  that  if  one-off
measurements  of  plasma  ﬁbrinogen  are  sampled  at  unspec-
iﬁed  time  points  without  taking  environmental  factors  into
account  and,  moreover,  in  individuals  from  heterogeneous
populations,  they  would  show  large  intra-individual  varia-
tion  and,  as  a  consequence,  their  use  as  markers  of  risk  may
be  limited.  Our  results  therefore  explain  why  some  other
authors  have  not  found  robust  associations  between  single
measurements  of  ﬁbrinogen  and  CVD.  For  example,  Kap-
toge  et  al.  found  that  ﬁbrinogen  was  associated  with  CVD
but  was  marginally  important  in  predictive  models  for  CVD
after  the  inclusion  of  the  standard  risk  factors  for  CVD  pre-
diction  (Emerging  Risk  Factors  Collaboration  et  al.,  2012;
Stulnig,  2013).  Similarly,  Mendelian  randomization  studies
that  were  focused  on  the  genetic  determinants  of  ﬁbrinogen
plasma  concentration,  and  not  on  the  reactivity,  found  no
evidence  for  a  causal  relationship  between  ﬁbrinogen  levels
and  cardiac  disease  (Keavney  et  al.,  2006;  Ken-Dror  et  al.,
2012).
Thus  the  novelty  of  our  analysis  lies  particularly  in  the
fact  that  we  have  linked  ﬁbrinogen  response  to  laboratory-
induced  acute  mental  stress  with  a robust  CVD  outcome
such  as  HS-CTnT.  One  previous  study  adopted  a  very  simi-
lar  approach  but  identiﬁed  hypertension  as  the  main  clinical
outcome  and  found  a  positive  association  between  ﬁbrino-
gen  response  and  hypertension  (Brydon  and  Steptoe,  2005).
We  think  that  our  new  ﬁnding  is  not  in  contradiction  with
this  previous  study  because  hypertension  is  closely  associ-
ated  with  mental  stress  (Armario  et  al.,  2003) and  is  a  more
distal  risk  factor  for  CVD  compared  to  HS-CTnT,  which  is  a
robust  proximal  marker  of  CVD.
Allostasis  is  a  convenient  framework  within  which  to
examine  the  association  between  mental  stress  and  cardio-
vascular  health.  Unfortunately,  in  this  study  we  could  not
explore  what  the  actual  causes  of  altered  allostatic  proﬁle
are.  Stress  reactivity  seemed  to  be  independent  from  age,
gender,  and  other  clinical  and  non-clinical  factors  related  to
CVD  and  to  health  in  general.  Also  atherosclerosis  seemed
not  to  interfere  with  allostatic  regulation,  although  it  was
found  that  tissue  factor  (extrinsic  coagulation  pathway)  is
present  in  the  matrix  of  the  necrotic  core  of  the  atheroscle-
rotic  plaque  (Wilcox  et  al.,  1989).
The  prevalence  of  detectable  HS-CTnT  in  our  British  sam-
ple  was  17.1%,  which  is  similar  to  levels  reported  (15.7%)  in
a  nationally  representative  CVD-free  population  sample  in
USA  (De  Lemos  et  al.,  2010).
Detectable  HS-CTnT  is  associated  with  noncardiac  condi-
tions  such  as  severe  renal  disease  (Irfan  et  al.,  2012;  Sharma
et  al.,  2006) and,  theoretically,  our  results  could  be  due  to
confounding  if  patients  with  renal  disease  are  more  likely  to
test  positive  at  mental  stress  tests.  However,  it  is  unlikely
that  this  mechanism  underlies  our  results  since  the  study
participants  were  free  from  any  chronic  conditions  at  the
time  of  testing,  as  explained  in  Section  2.
Non-calciﬁed  coronary  plaques  are  less  detectable  using
cardiac  computerized  tomography  and  that  may  partly
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Table  4  Multiple  logistic  regression  models  for  the  association  between  baseline  ﬁbrinogen,  ﬁbrinogen  response  to  mental  stress  tasks,  or  ﬁbrinogen  recovery  and  plasma
detectable HS-CTnT,  for  491  disease-free  participants  drawn  from  the  Whitehall  II  epidemiological  cohort  between  2006  and  2008  in  England.
Model  for  detectable  HS-cTnT  (outcome
variable)
Exposure  variable
Baseline  ﬁbrinogen
(OR  for  1  g/L)
Fibrinogen  response
(OR  for  10%  increase)
Fibrinogen  recovery
(OR  for  10%  decrease)
OR  (95%  CI) P  OR  (95%  CI) P  OR  (95%  CI) P
1.  Crude  association 1.41 (0.97—2.04) 0.072 0.63 (0.45—0.88) 0.007 0.99 (0.96—1.01) 0.365
2.  Adjusted  for  age,  gender,  and  baseline
ﬁbrinogen  when  exposure  is  ﬁbrinogen
response  or  recovery
1.35 (0.89—2.05) 0.154 0.61 (0.41—0.90) 0.014 0.99 (0.96—1.03) 0.601
3.  With  further  adjustment  for  latest  grade
of employment,  smoking,  alcohol
consumption,  and  physical  activity
1.27 (0.83—1.95) 0.265 0.61  (0.41—0.91)  0.015  0.99  (0.96—1.03)  0.683
4. With  further  adjustment  for  systolic  and
diastolic  blood  pressure,  LDL,  total
cholesterol/HDL  ratio,  triglycerides,
glycated  haemoglobin,  and  BMI
1.13 (0.71—1.79) 0.607 0.57 (0.37—0.88)  0.011  0.99  (0.95—1.02)  0.480
5. With  further  adjustment  for  baseline
values  of  CRP,  salivary  cortisol,  IL6,
vWF,  and  MCP-1
1.05  (0.58—1.91)  0.878  0.53  (0.34—0.83)  0.006  0.98  (0.94—1.02)  0.250
6. With  further  adjustment  for  response
values  of  salivary  cortisol,  IL6,  vWF,  and
MCP-1
0.97 (0.50—1.85)  0.919  0.49  (0.30—0.81)  0.006  0.98  (0.94—1.02)  0.284
7. With  further  adjustment  for  coronary
calciﬁcation  (Agatston  score  in  4
categories)
0.92 (0.48—1.76) 0.798  0.49  (0.30—0.82)  0.007  0.98  (0.94—1.02)  0.246
All variables were measured at baseline with the exception of response variables (calculated as the proportional increase from baseline to immediately post task) and ﬁbrinogen recovery
(calculated as the proportional decrease from immediate post task to 45 min post task). HS-CTnT was measured at 75 min  post task.
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explain  why  CAC  did  not  attenuate  the  association  between
ﬁbrinogen  and  HS-CTnT.  However,  there  is  a  direct  rela-
tionship  between  the  number  of  calciﬁed  plaques  present
and  total  plaque  burden,  and  CAC  correlates  highly  with
the  severity  of  coronary  artery  disease,  so  the  absence  of
calciﬁcation  implies  that  there  is  probably  little  signiﬁcant
coronary  artery  disease  (Arad  et  al.,  2000).  On  the  other
hand,  it  has  been  argued  that  raised  troponin  T  may  be  due
to  occult  or  undetected  plaque  rupture  (Korosoglou  et  al.,
2011)  and  it  is  known  that  plaque  rupture  is  a  relatively  com-
mon  event  that  is  usually  not  followed  by  an  acute  cardiac
event  (Arbab-Zadeh  et  al.,  2012).  This  process  may  have
operated  in  our  patients  with  minimal  CAC  score  levels  and
detectable  HS-CTnT.  However  this  is  unlikely  to  invalidate
our  results  because  atherosclerosis  may  lie  on  the  causal
pathway  between  ﬁbrinogen  and  HS-CTnT  and  also  it  cannot
give  an  alternative  explanation  to  the  dynamics  of  associa-
tion  that  we  found.
Fibrinogen  was  not  associated  with  CAC  in  our  sam-
ple.  This  may  be  due  to  the  fact  that  ﬁbrinogen  does  not
directly  interfere  with  the  phenomenon  of  plaque  calciﬁ-
cation  and/or  that  ﬁbrinogen  and  CAC  can  also  operate  on
parallel  pathways  leading  to  troponin  T  release.
A  single  measure  of  plasma  HS-CTnT  concentration  can-
not  be  regarded  as  a  robust  test  if  it  is  not  stable  over  time,
i.e.  if  it  shows  high  intra-individual  short-term  variation.
However,  the  results  from  the  ARIC  study  showed  that  HS-
CTnT  intra-individual  variability  over  6  weeks  is  almost  null,
with  a  correlation  coefﬁcient  of  0.94  (Agarwal  et  al.,  2011).
Thus,  although  our  study  collected  HS-CTnT  after  a  brief
moderately  stressful  behavioural  challenge,  it  is  improba-
ble  that  troponin  T  was  released  in  response  to  this  task.  To
the  contrary,  we  hypothesized  that  higher  baseline  ﬁbrino-
gen  is  indicative  of  chronic  allostatic  load  that  might  lead  to
blunted  reactivity  and  impaired  recovery,  and  this  process  is
likely  to  be  relevant  to  the  aetiology  of  heart  disease,  which
can  be  detected  by  chronic  elevation  in  HS-CTnT  concentra-
tion.
Our  study  involved  participants  free  of  CVD  because  we
are  interested  in  the  primary  prevention  of  heart  disease.
This  approach  has  the  disadvantage  of  generating  results
that  are  not  necessarily  applicable  to  the  general  popula-
tion.  Our  results  could  be  due  to  selection  bias  if  people
at  the  initial  stages  of  the  disease  or  people  who  already
had  CVD  episodes  have  different  patterns  of  associations
compared  with  healthy  individuals.
The  assay  that  we  have  used  to  measure  the  concentra-
tion  of  cardiac  troponin  T  in  the  peripheral  blood  plasma  had
high  sensitivity  but  we  cannot  be  sure  that  the  participants
who  scored  zero  really  had  no  troponin  T  in  their  plasma.
Although  the  lower  detection  limit  of  the  assay  was  very
low  (3  ng/L),  some  participants  may  have  had  lower  non-
zero  but  undetectable  concentrations.  These  measurement
issues  may  have  distorted  our  results  if  such  participants
tended  to  have  higher  ﬁbrinogen  reaction  to  the  mental
stress  tests.
This  is  a  cross-sectional  study  and  therefore  we  cannot
determine  the  causal  sequence.  Blunted  ﬁbrinogen  stress
responsivity  may  contribute  to  early  signs  of  CVD,  or  peo-
ple  at  an  early  stage  of  cardiac  disease  may  be  more  prone
to  disturbed  stress  responses.  In  fact,  cardiac  troponins
are  the  most  sensitive  and  speciﬁc  biochemical  markers  of
myocardial  damage  (Jaffe  et  al.,  2000),  but  their  eleva-
tion  can  be  due  to  a  variety  of  reasons  such  as  pericarditis,
myocarditis,  and  pulmonary  embolism  (Roongsritong  et  al.,
2004).  However,  it  is  unlikely  that  the  undetected  presence
of  those  conditions  can  explain  our  ﬁndings  since  no  partic-
ipants  reported  any  symptoms  or  signs  of  cardiac  or  kidney
disease,  had  any  previous  diagnosis  or  treatment  for  hyper-
tension,  inﬂammatory  disease  or  allergies,  and  did  not  show
any  electrocardiographic  indications  of  cardiac  disease  on
tests  carried  out  over  more  than  20  years  in  the  Whitehall  II
study.
The  role  of  ﬁbrinogen  in  the  coagulation  cascade  is  com-
plex  because  ﬁbrinogen  is  not  only  the  product  but  also
the  origin  of  several  reactions  within  a  system  of  mutually
reinforcing  and  mutually  rebalancing  agents.  For  exam-
ple,  the  breakdown  of  ﬁbrinogen  has  a  pro-haemostatic
function  on  the  one  hand,  given  that  this  phenomenon
is  the  only  route  for  the  formation  of  ﬁbrin,  and  has  an
anti-haemostatic  function  on  the  other  hand,  since  unbro-
ken  ﬁbrinogen  induces  platelet  adhesion  and  activation
(Chiumiento  et  al.,  2007;  Kamath  and  Lip,  2003).  In  our
study,  for  some  people  ﬁbrinogen  levels  increased  by  more
than  10%  after  a  brief  stress  test  and  it  is  plausible  that
the  released  ﬁbrinogen  came  from  activated  platelets  rather
than  from  liver  production,  which  can  take  several  hours  to
be  completed.  In  fact,  platelets  exhibit  both  adrenergic  and
dopaminergic  receptors  that  are  inﬂuenced  by  different  cat-
echolamines  and  it  has  been  shown  that  physiological  and
pathological  conditions  causing  sympathoadrenal  activation
in  vivo,  e.g.  mental  stress,  modify  the  circulating  platelet
populations  and  modulate  platelet  reactivity  through  an
increase  in  circulating  catecholamines  (Anfossi  and  Trovati,
1996).
The  fact  that  heart  rate  response  and  blood  pressure
response  were  not  associated  with  detectable  plasma  lev-
els  of  HS-CTnT  suggests  that  the  stress  response  dynamics
leading  to  heart  disease  may  be  peculiar  for  some  CVD  risk
factors  only.
In conclusion,  greater  ﬁbrinogen  responses  to  mental
stress  are  associated  with  lower  likelihood  of  detectable
high-sensitivity  troponin  T  plasma  concentration,  indepen-
dently  of  basal  ﬁbrinogen.  Thus,  a  more  dynamic  ﬁbrinogen
response  appears  to  be  advantageous  for  cardiovascular
health.  Further  research  is  needed  to  ascertain  the  role  of
ﬁbrinogen  in  the  pathophysiology  of  cardiovascular  disease
and  the  causes  of  impaired  allostatic  adaptation  to  mental
stress.
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